Erratum: HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocytederived cells (Journal of Biological Chemistry (2011) 108, 17 (7166-7171) DOI: 10.1073/pnas.1016086108);HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 17, 2011, Pages 7166-7171

  Feig, Jonathan E ^a   Rong, James X ^a,c   Shamir, Raanan ^a,d   Sanson, Marie ^a   Vengrenyuk, Yuliya ^a   Liu, Jianhua ^b   Rayner, Katey ^a   Moore, Kathryn ^a   Garabedian, Michael ^a   Fisher, Edward A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c GLAXOSMITHKLINE   (United States)

^d SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Alternative activation; Arginase I

Indexed keywords

CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR7; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; INFLAMMATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MUS;

EID: 79955552375     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1111090108     Document Type: Erratum

References (59)

1. Castelli WP, et al. (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256:2835-2838. (Pubitemid 17178361)
2. Feig JE, Shamir R, Fisher EA (2008) Atheroprotective effects of HDL: Beyond reverse cholesterol transport. Curr Drug Targets 9:196-203. (Pubitemid 351843600)
3. Franceschini G (2001) Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. Am J Cardiol 88(12A):9N-13N.
4. Gordon DJ, Rifkind BM (1989) High-density lipoprotein-The clinical implications of recent studies. N Engl J Med 321:1311-1316. (Pubitemid 19267219)
5. Miller NE, Miller GJ (1975) Letter: High-density lipoprotein and atherosclerosis. Lancet 1:1033.
6. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM (1991) Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353:265-267. (Pubitemid 21896769)
7. Pászty C, Maeda N, Verstuyft J, Rubin EM (1994) Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 94:899-903.
8. Plump AS, Scott CJ, Breslow JL (1994) Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 91:9607-9611. (Pubitemid 24297964)
9. Choudhury RP, et al. (2004) High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation. Arterioscler Thromb Vasc Biol 24:1904-1909. (Pubitemid 39350311)
10. Shah PK, et al. (2001) High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 103:3047-3050. (Pubitemid 32587849)
11. Tangirala RK, et al. (1999) Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 100:1816-1822. (Pubitemid 29498389)
12. Tsukamoto K, Tangirala R, Chun SH, Puré E, Rader DJ (1999) Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19:2162-2170. (Pubitemid 29422249)
13. Badimon JJ, Badimon L, Fuster V (1990) Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 85:1234-1241. (Pubitemid 20123768)
14. Nissen SE, et al. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial. JAMA 290:2292-2300. (Pubitemid 37430562)
15. Reis ED, et al. (2001) Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg 34:541-547. (Pubitemid 33661190)
16. Chereshnev I, et al. (2003) Mouse model of heterotopic aortic arch transplantation. J Surg Res 111:171-176. (Pubitemid 36808906)
17. Trogan E, et al. (2004) Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler Thromb Vasc Biol 24:1714-1719. (Pubitemid 39180900)
18. Llodrá J, et al. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 101:11779-11784. (Pubitemid 39095371)
19. Trogan E, et al. (2006) Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci USA 103:3781-3786. (Pubitemid 43376632)
20. Nicholls SJ, et al. (2007) Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 297:499-508. (Pubitemid 46220805)
21. Swirski FK, et al. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117:195-205. (Pubitemid 46048466)
22. Tacke F, et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:185-194. (Pubitemid 46048465)
23. Tacke F, et al. (2006) Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J Exp Med 203:583-597.
24. Tacke F, Randolph GJ (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211:609-618.
25. He T, Tang C, Xu S, Moyana T, Xiang J (2007) Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity. Cell Mol Immunol 4:105-111.
26. Scanu AM, Edelstein C (2008) HDL: Bridging past and present with a look at the future. FASEB J 22:4044-4054.
27. Tabet F, Rye KA (2009) High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 116:87-98.
28. Rong JX, et al. (2001) Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation 104:2447-2452. (Pubitemid 33108379)
29. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23-35.
30. Teupser D, et al. (2006) Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscler Thromb Vasc Biol 26:365-371. (Pubitemid 43732201)
31. Thomas AC, et al. (2007) Genomics of foam cells and nonfoamy macrophages from rabbits identifies arginase-I as a differential regulator of nitric oxide production. Arterioscler Thromb Vasc Biol 27:571-577.
32. Dumont J, et al. (2007) Association of arginase 1 gene polymorphisms with the risk of myocardial infarction and common carotid intima media thickness. J Med Genet 44: 526-531. (Pubitemid 47325740)
33. McGill HC, Jr., McMahan CA, Gidding SS (2008) Preventing heart disease in the 21st century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 117:1216-1227.
34. Williams KJ, Feig JE, Fisher EA (2008) Rapid regression of atherosclerosis: Insights from the clinical and experimental literature. Nat Clin Pract Cardiovasc Med 5:91-102. (Pubitemid 351168064)
35. Duffy D, Rader DJ (2009) Update on strategies to increase HDL quantity and function. Nat Rev Cardiol 6:455-463.
36. Rubin EM, Ishida BY, Clift SM, Krauss RM (1991) Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc Natl Acad Sci USA 88:434-438. (Pubitemid 21915479)
37. Walsh A, Ito Y, Breslow JL (1989) High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. J Biol Chem 264:6488-6494. (Pubitemid 19106733)
38. Damås JK, et al. (2007) Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol 27:614-620.
39. Förster R, et al. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33. (Pubitemid 29468627)
40. Angeli V, et al. (2004) Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21:561-574. (Pubitemid 39370511)
41. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969.
42. Bouhlel MA, et al. (2007) PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 6: 137-143. (Pubitemid 47189091)
43. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453-461. (Pubitemid 351599757)
44. Odegaard JI, et al. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447:1116-1120. (Pubitemid 47014427)
45. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175-184. (Pubitemid 46048464)
46. Khallou-Laschet J, et al. (2010) Macrophage plasticity in experimental atherosclerosis. PLoS ONE 5:e8852.
47. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF (2009) The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem 284: 32336-32343.
48. Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219-246.
49. Yvan-Charvet L, Wang N, Tall AR (2010) Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol 30: 139-143.
50. Zhu X, et al. (2008) Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem 283:22930-22941.
51. Smythies LE, et al. (2010) Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. Am J Physiol Cell Physiol 298:C1538-C1548.
52. Barter P, et al.; Treating to New Targets Investigators (2007) HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357:1301-1310.
53. Trogan E, et al. (2002) Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 99:2234-2239. (Pubitemid 34169044)
54. Trogan E, Fisher EA (2005) Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions. Methods Mol Biol 293:221-231.
55. Li AC, et al. (2004) Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest 114:1564-1576. (Pubitemid 40385547)
56. Martinez FO, Gordon S, Locati M, Mantovani A (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J Immunol 177:7303-7311. (Pubitemid 44715100)
57. Rong JX, Shapiro M, Trogan E, Fisher EA (2003) Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 100:13531-13536. (Pubitemid 37444776)
58. Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-337. (Pubitemid 9110191)
59. Shen Z, Reznikoff G, Dranoff G, Rock KL (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158: 2723-2730. (Pubitemid 127470530)